About: Lipodystrophy   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

Changes in skin's fatty underlayer where insulin is injected. Lipoatrophy is a depression in the skin; lipohypertrophy is a thickening or enlargement (raised area) of tissue. Injecting any insulin at the same site repeatedly over time can cause a lipodystrophy: either lipoatrophy or lipohypertrophy. Either makes absorption unreliable, and can possibly lead to hypoglycemia or hyperglycemia because insulin is not absorbed well from thickened tissue areas. But varying the injection site can cause variability in action profile, too. This BD Diabetes page illustrates the most common areas humans with diabetes inject insulin and explains how absorption differs in various areas of the human body. This is true for ALL insulins.

AttributesValues
rdfs:label
  • Lipodystrophy
rdfs:comment
  • Changes in skin's fatty underlayer where insulin is injected. Lipoatrophy is a depression in the skin; lipohypertrophy is a thickening or enlargement (raised area) of tissue. Injecting any insulin at the same site repeatedly over time can cause a lipodystrophy: either lipoatrophy or lipohypertrophy. Either makes absorption unreliable, and can possibly lead to hypoglycemia or hyperglycemia because insulin is not absorbed well from thickened tissue areas. But varying the injection site can cause variability in action profile, too. This BD Diabetes page illustrates the most common areas humans with diabetes inject insulin and explains how absorption differs in various areas of the human body. This is true for ALL insulins.
sameAs
dcterms:subject
abstract
  • Changes in skin's fatty underlayer where insulin is injected. Lipoatrophy is a depression in the skin; lipohypertrophy is a thickening or enlargement (raised area) of tissue. Injecting any insulin at the same site repeatedly over time can cause a lipodystrophy: either lipoatrophy or lipohypertrophy. Either makes absorption unreliable, and can possibly lead to hypoglycemia or hyperglycemia because insulin is not absorbed well from thickened tissue areas. But varying the injection site can cause variability in action profile, too. This BD Diabetes page illustrates the most common areas humans with diabetes inject insulin and explains how absorption differs in various areas of the human body. This is true for ALL insulins. Rotating injection sites can be helpful in avoiding/eliminating these. At times, the injection technique is the cause and needs changing.
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software